21 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
to fostering an inclusive culture, science-focused approach and urgency for patients positions us well to advance the company through its next phase.”
About
8-K
EX-99.2
f0zzy
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
7f9af
26 Apr 22
Definitive proxy
4:05pm
10-K
xz9icxwqw1x91esj
1 Mar 22
Annual report
4:07pm
10-Q
r3wn3pz07w7 12zed1
2 Dec 21
Quarterly report
4:15pm
8-K
EX-99.1
hoza1 znh
2 Dec 21
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
8:00am
424B4
hfiptic 2v
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
emf538dd
18 Oct 21
IPO registration (amended)
6:04am
S-1
43z71no20u xu
1 Oct 21
IPO registration
4:49pm
DRS/A
iht37tng6 iv
14 Sep 21
Draft registration statement (amended)
12:00am